High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage

Hallermann, Christian; Kaune Kjell, Matthias; Tiemann, Markus; Kunze, Ekkehard; Griesinger, Frank; Mitteldorf, Christina; Bertsch, Hans-Peter; Neumann, Christine; Kaune, Kjell Matthias; Kaune, Matthias Kjell
July 2007
Annals of Hematology;Jul2007, Vol. 86 Issue 7, p509
Academic Journal
journal article
In patients suffering from primary cutaneous lymphomas, secondary malignancies of various origin may develop. However, the frequency of a second neoplasm deriving from another lymphoid lineage is still unclear and may be underestimated. We screened all our patients with primary cutaneous lymphomas from a 4-year recruitment period for a coexisting secondary lymphoproliferative disorder. The cohort comprised of a total of 82 patients with primary cutaneous lymphomas, 62 with primary cutaneous T-cell lymphoma (CTCL), 18 with primary cutaneous B-cell lymphomas, and two with CD4+/CD56+ hematodermic neoplasm/blastic lymphomas. Seven patients (8.5%) were identified with a coexisting lymphoma of a different lymphoid lineage. Four patients with Sézary syndrome (SS) suffered from systemic B-cell lymphoma. Two of these developed SS after chemotherapy of their B-cell lymphoma. The other three patients with various types of skin lymphomas (SS, Mycosis fungoides [MF], primary cutaneous marginal zone lymphoma) developed Hodgkin's disease (hairy cell leukemia). Our data indicate that patients with primary cutaneous lymphomas have an elevated risk for the development of a secondary lymphoproliferative disorder even without previous chemotherapy. Possible explanations for this association include a genetic predisposition, alterations in early progenitor cells, underlying viral infections, and/or stimulation of a B-cell clone by the malignant helper T cells of the primary CTCL and vice versa.


Related Articles

  • Mycosis fungoides bullosa: a case report and review of the literature. Kneitz, Hermann; Bröcker, Eva-B.; Becker, Jürgen C. // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Mycosis fungoides, the most common type of cutaneous T-cell lymphoma, can manifest in a variety of clinical and histological forms. Bulla formation is an uncommon finding in mycosis fungoides and only approximately 20 cases have been reported in the literature. Case presentation:...

  • Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome. Krejsgaard, T; Odum, N; Geisler, C; Wasik, M A; Woetmann, A // Leukemia (08876924);Mar2012, Vol. 26 Issue 3, p424 

    Cutaneous T-cell lymphoma (CTCL) is the term for diseases characterized by primary accumulation of malignant T cells in the skin. Patients with the two predominant clinical forms of CTCL called mycosis fungoides (MF) and Sézary syndrome (SS) characteristically develop severe immunodeficiency...

  • Romidepsin in the Treatment of T-Cell Lymphoma. Yang, Lily P.H. // BioDrugs;2011, Vol. 25 Issue 6, p393 

    No abstract available.

  • No Evidence of KSHV/HHV-8 in Mycosis Fungoides or Associated Disorders. Henghold II, William B.; Purvis, Scott F.; Schaffer, John; Chou-Zen Giam; Wood, Gary S. // Journal of Investigative Dermatology;Jun97, Vol. 108 Issue 6, p920 

    The recently discovered human virus known as Kaposi's sarcoma-associated herpesvirus (KSHV) or human herpesvirus-8 (HHV-8) has been associated with body-cavity-based lymphomas in AIDS patients. It is most closely related to two other herpesviruses, the Epstein-Barr virus and herpesvirus saimiri,...

  • More or Less: Copy Number Alterations in Mycosis Fungoides. Lin, William M.; Girardi, Michael // Journal of Investigative Dermatology;Apr2010, Vol. 130 Issue 4, p926 

    Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma (CTCL), a heterogeneous group of non-Hodgkin’s lymphomas of skin-homing T cells. MF may vary from limited patchy skin disease to extensive cutaneous plaque and tumor involvement to extracutaneous compartments of...

  • Novel therapeutic agents for cutaneous T-Cell lymphoma. Jain, Salvia; Zain, Jasmine; O'Connor, Owen // Journal of Hematology & Oncology;2012, Vol. 5 Issue 1, p24 

    Abstract: Mycosis fungoides (MF) and Sezary Syndrome (SS) represent the most common subtypes of primary Cutaneous T-cell lymphoma (CTCL). Patients with advanced MF and SS have a poor prognosis leading to an interest in the development of new therapies with targeted mechanisms of action and...

  • TYPE D LYMPHOMATOID PAPULOSIS: AN UNCOMMON VARIANT. A CASE REPORT AND REVIEW OF THE LITERATURE. Paguaga, Gladys Alejandra; Pernillo, Orlando Rodas; Sarti, Helga María // Our Dermatology Online / Nasza Dermatologia Online;Oct2014, Vol. 5 Issue 4, p401 

    Lymphomatoid papulosis (LyP) is an indolent form of primary cutaneous T-cell lymphoma, currently classified together with primary cutaneous anaplastic large T-cell lymphoma within the spectrum of CD30-positive lymphoproliferative disorders. It is characterized by presenting as a clinically...

  • Mycosis fungoides with unusual vitiligo-like presentation. Des, Jayenta Kumar; Gangopadhyay, Asok Kumar // Indian Journal of Dermatology, Venereology & Leprology;Sep/Oct2004, Vol. 70 Issue 5, p304 

    Mycosis fungoides (MF), the commonest variant of primary cutaneous T cell lymphoma (CTCL), is relatively uncommon among the Asians. Hypopigmented mycosis fungoides is a rare variant usually observed in dark-skinned individuals, especially children. Hypopigmented MF usually responds well to...

  • Bexarotene.  // Reactions Weekly;9/3/2005, Issue 1067, p6 

    Discusses research being done on bexarotene treatment of late-stage mycosis fungoides or Sezary syndrome in patients with cutaneous lymphoma. Reference to a study by S. A. Bouwis et al published in a June 2005 issue of the "Journal of the American Academy of Dermatology"; Effects of bexaretene...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics